rossta 10 mg tabletki powlekane
swyssi ag - rosuvastatinum - tabletki powlekane - 10 mg
rossta 40 mg tabletki powlekane
swyssi ag - rosuvastatinum - tabletki powlekane - 40 mg
akraz 3 mg + 0,02 mg tabletki
mylan s.a.s. - drospirenonum + ethinylestradiolum - tabletki - 3 mg + 0,02 mg
etoricoxib teva 30 mg tabletki powlekane
teva pharmaceuticals polska sp. z o.o. - etoricoxibum - tabletki powlekane - 30 mg
etoricoxib teva 60 mg tabletki powlekane
teva pharmaceuticals polska sp. z o.o. - etoricoxibum - tabletki powlekane - 60 mg
etoricoxib teva 90 mg tabletki powlekane
teva pharmaceuticals polska sp. z o.o. - etoricoxibum - tabletki powlekane - 90 mg
etoricoxib teva 120 mg tabletki powlekane
teva pharmaceuticals polska sp. z o.o. - etoricoxibum - tabletki powlekane - 120 mg
takhzyro
takeda pharmaceuticals international ag ireland branch - lanadelumab - angioedemas, dziedziczny - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - choroba płuc, przewlekła obturacyjna - preparaty do obturacyjne choroby dróg oddechowych, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
lumoxiti
astrazeneca ab - moxetumomab pasudotox - białaczka, włochate komórki - Środki przeciwnowotworowe - lumoxiti as monotherapy is indicated for the treatment of adult patients with relapsed or refractory hairy cell leukaemia (hcl) after receiving at least two prior systemic therapies, including treatment with a purine nucleoside analogue (pna).